🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate Pharmacokinetics parameters of ...
Status
Completed
Location
Jiangsu Province Hospital
Start Date
2016-11
Trial ID
NCT03001609
Treatments Being Tested
The study is a single-arm, multi-center, open-label clinical trial. The stu...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-05-18
Trial ID
NCT03300115
Treatments Being Tested
AC0010MA is a new, irreversible, Epidermal Growth Factor Receptor (EGFR) mu...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2015-05
Trial ID
NCT02448251
Treatments Being Tested
A Phase III, Open-Label, Randomized Multicenter Study to Compare AC0010 and...
Status
Withdrawn
Location
Beijing Cancer Hospital
Start Date
2018-12
Trial ID
NCT03058094
Treatments Being Tested
The purpose of this study is to evaluate safety and efficacy of male Patien...
Status
Completed
Location
Jiangsu Province Hospital
Start Date
2016-11
Trial ID
NCT03053219
Treatments Being Tested
This is an open label, dose escalation, phase I study to determine the reco...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2017-03-17
Trial ID
NCT03060850
Treatments Being Tested
AC0010 is a novel, potent, small molecule irreversible tyrosine kinase inhi...
Status
Unknown
Location
307 Hospital of PLA
Start Date
2015-01
Trial ID
NCT02330367
Treatments Being Tested